{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:40:47Z","timestamp":1793277647070,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Large Research Project","award":["RGP2\/530\/45"],"award-info":[{"award-number":["RGP2\/530\/45"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"DOI":"10.1186\/s13065-025-01448-8","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T05:08:39Z","timestamp":1742015319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Integrating green analytical chemistry and analytical quality by design: an innovative approach for RP-UPLC method development of ensifentrine in bulk and inhalation formulations"],"prefix":"10.1186","volume":"19","author":[{"given":"Mohan Goud","family":"Vanga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5693-2953","authenticated-orcid":false,"given":"Sarad Pawar Naik","family":"Bukke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0854-3734","authenticated-orcid":false,"given":"Praveen Kumar","family":"Kusuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayapa Reddy","family":"Narapureddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrashekar","family":"Thalluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,15]]},"reference":[{"key":"1448_CR1","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2147\/COPD.S413436","volume":"18","author":"JF Donohue","year":"2023","unstructured":"Donohue JF, Rheault T, MacDonald-Berko M, Bengtsson T, Rickard K. Ensifentrine as a novel, inhaled treatment for patients with COPD. Int J Chron Obstruct Pulmon Dis. 2023;18:1611\u201322.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1448_CR2","unstructured":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2023 report. Global initiative for chronic obstructive lung disease (GOLD). 2023. https:\/\/goldcopd.org\/. Accessed 5 July 2024."},{"key":"1448_CR3","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0095-2019","volume":"28","author":"M Cazzola","year":"2019","unstructured":"Cazzola M, Rogliani P, Matera MG. The future of bronchodilation: looking for new classes of bronchodilators. Eur Respir Rev. 2019;28: 190095.","journal-title":"Eur Respir Rev"},{"key":"1448_CR4","unstructured":"Lipworth et al. Phosphodiesterase 3 and 4 inhibitors in chronic obstructive pulmonary disease. 2017."},{"key":"1448_CR5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/bcpt.12209","volume":"114","author":"KH Abbott-Banner","year":"2014","unstructured":"Abbott-Banner KH, Page CP. Dual pde 3\/4 and pde 4 inhibitors: novel treatments for copd and other inflammatory airway diseases. Basic Clin Pharmacol Toxicol. 2014;114:365\u201376.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1448_CR6","unstructured":"Singh et al. Ensifentrine (RPL554) in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled phase 3 trial. 2022."},{"key":"1448_CR7","unstructured":"Giembycz et al. Dual Phosphodiesterase 3 and 4 Inhibitors: A New Therapeutic Approach For Chronic Obstructive Pulmonary Disease. 2018."},{"key":"1448_CR8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1164\/rccm.202306-0944OC","volume":"208","author":"A Anzueto","year":"2023","unstructured":"Anzueto A, Barjaktarevic IZ, Siler TM, Rheault T, Bengtsson T, Rickard K, et al. Ensifentrine, a novel phosphodiesterase 3 and 4 inhibitor for the treatment of chronic obstructive pulmonary disease: randomized, double-blind, placebo-controlled, multicenter phase III trials (the ENHANCE Trials). Am J Respir Crit Care Med. 2023;208:406\u201316.","journal-title":"Am J Respir Crit Care Med"},{"key":"1448_CR9","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s40265-024-02081-w","volume":"84","author":"SJ Keam","year":"2024","unstructured":"Keam SJ. Ensifentrine: first approval. Drugs. 2024;84:1157\u201363.","journal-title":"Drugs"},{"key":"1448_CR10","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1124\/jpet.105.099192","volume":"318","author":"V Boswell-Smith","year":"2006","unstructured":"Boswell-Smith V, Spina D, Oxford AW, Comer MB, Seeds EA, Page CP. The pharmacology of two novel long-acting phosphodiesterase 3\/4 inhibitors, RPL554 [9,10-dimethoxy-2(2,4,6-trimethylphenylimino)-3-( N -carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2 H -pyrimido[6,1- a ]isoquinolin-4-one] and RPL565 [6,7-Dihydro-2-(2,6-diisopropylphenoxy)-9,10-dimethoxy-4 H -pyrimido[6,1- a ]isoquinolin-4-one]. J Pharmacol Exp Ther. 2006;318:840\u20138.","journal-title":"J Pharmacol Exp Ther"},{"key":"1448_CR11","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.tips.2024.08.002","volume":"45","author":"S Hubert","year":"2024","unstructured":"Hubert S, K\u00f6k-Carri\u00e8re A, De Ceuninck F. Ensifentrine (Ohtuvayre\u2122) for chronic obstructive pulmonary disease. Trends Pharmacol Sci. 2024;45:941\u20132.","journal-title":"Trends Pharmacol Sci"},{"key":"1448_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2023.109717","volume":"196","author":"DA Ahmed","year":"2024","unstructured":"Ahmed DA, Hussein OG, Rezk MR, Abdelkawy M, Rostom Y. Impressive merger between green analytical approaches and quality-by- design for alcaftadine determination in eye drops and rabbit aqueous humor; application to stability study by two validated chromatographic methods. Microchem J. 2024;196: 109717.","journal-title":"Microchem J"},{"key":"1448_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2023.115598","volume":"235","author":"OG Hussein","year":"2023","unstructured":"Hussein OG, Ahmed DA, Rezk MR, Abdelkawy M, Rostom Y. Exquisite integration of quality-by-design and green analytical approaches for simultaneous determination of xylometazoline and antazoline in eye drops and rabbit aqueous humor, application to stability study. J Pharm Biomed Anal. 2023;235: 115598.","journal-title":"J Pharm Biomed Anal"},{"key":"1448_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2020.105711","volume":"160","author":"EM Abdel-Moety","year":"2021","unstructured":"Abdel-Moety EM, Rezk MR, Wadie M, Tantawy MA. A combined approach of green chemistry and quality-by-design for sustainable and robust analysis of two newly introduced pharmaceutical formulations treating benign prostate hyperplasia. Microchem J. 2021;160: 105711.","journal-title":"Microchem J"},{"key":"1448_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijms.2023.117070","volume":"490","author":"SR Patra","year":"2023","unstructured":"Patra SR, Bali A, Saha M, Singh J, Shekhar S. Method validation and characterization of stress degradation products of gefitinib through UPLC-UV\/PDA and LC\u2013MS\/TOF studies. Int J Mass Spectrom. 2023;490: 117070.","journal-title":"Int J Mass Spectrom"},{"key":"1448_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5549","volume":"37","author":"NS Lakka","year":"2023","unstructured":"Lakka NS, Kuppan C, Vadagam N, Reddamoni SY, Muthusamy C. Degradation pathways and impurity profiling of the anticancer drug apalutamide by HPLC and LC\u2013MS\/MS and separation of impurities using Design of Experiments. Biomed Chromatogr. 2023;37: e5549.","journal-title":"Biomed Chromatogr"},{"key":"1448_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.greeac.2023.100090","volume":"8","author":"VN Bhukya","year":"2024","unstructured":"Bhukya VN, Beda DP. Implementation of green analytical principles to develop and validate the HPLC method for the separation and identification of degradation products of Panobinostat, and its characterization by using LC-QTOF-MS\/MS and its in-silico toxicity prediction using ADMET software. Green Anal Chem. 2024;8: 100090.","journal-title":"Green Anal Chem"},{"key":"1448_CR18","doi-asserted-by":"publisher","first-page":"13896","DOI":"10.1039\/D2RA00966H","volume":"12","author":"MY Fares","year":"2022","unstructured":"Fares MY, Hegazy MA, El-Sayed GM, Abdelrahman MM, Abdelwahab NS. Quality by design approach for green HPLC method development for simultaneous analysis of two thalassemia drugs in biological fluid with pharmacokinetic study. RSC Adv. 2022;12:13896\u2013916.","journal-title":"RSC Adv"},{"key":"1448_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2022.463380","volume":"1679","author":"SK Muchakayala","year":"2022","unstructured":"Muchakayala SK, Katari NK, Saripella KK, Schaaf H, Marisetti VM, Ettaboina SK, et al. Implementation of analytical quality by design and green chemistry principles to develop an ultra-high performance liquid chromatography method for the determination of fluocinolone acetonide impurities from its drug substance and topical oil formulations. J Chromatogr A. 2022;1679: 463380.","journal-title":"J Chromatogr A"},{"key":"1448_CR20","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3390\/molecules23051065","volume":"23","author":"M Yabr\u00e9","year":"2018","unstructured":"Yabr\u00e9 M, Ferey L, Som\u00e9 IT, Gaudin K. Greening reversed-phase liquid chromatography methods using alternative solvents for pharmaceutical analysis. Molecules. 2018;23:1065.","journal-title":"Molecules"},{"key":"1448_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13065-023-00942-1","volume":"17","author":"SG Elsheikh","year":"2023","unstructured":"Elsheikh SG, Hassan AME, Fayez YM, El-Mosallamy SS. Green analytical chemistry and experimental design: a combined approach for the analysis of zonisamide. BMC Chem. 2023;17:38.","journal-title":"BMC Chem"},{"key":"1448_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/10826076.2023.2276283","volume":"46","author":"MA Shaik","year":"2023","unstructured":"Shaik MA, Manchuri KM, Nayakanti D. A novel UHPLC-MS\/MS method for trace level identification and quantification of genotoxic impurity 2-(2-chloroethoxy) ethanol in quetiapine fumarate. J Liq Chromatogr Relat Technol. 2023;46:325\u201334.","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"1448_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5805","volume":"38","author":"SM Ali","year":"2024","unstructured":"Ali SM, Moorthy MK, Devanna N. A novel liquid chromatography with quadrupole time-of-flight-tandem mass spectroscopy method for ultra-trace level identification and quantification of the genotoxic impurity 2,6-diamino-5-nitropyrimidin-4(3H)-one in valganciclovir hydrochloride. Biomed Chromatogr. 2024;38: e5805.","journal-title":"Biomed Chromatogr"},{"key":"1448_CR24","unstructured":"ICH Topic Q 1 A (R2). Stability testing of new drug substances and products. European medicines agency. 2003."},{"key":"1448_CR25","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0731-7085(02)00047-X","volume":"28","author":"M Bakshi","year":"2002","unstructured":"Bakshi M, Singh S. Development of validated stability-indicating assay methods\u2014critical review. J Pharm Biomed Anal. 2002;28:1011\u201340.","journal-title":"J Pharm Biomed Anal"},{"key":"1448_CR26","unstructured":"Center for drug evaluation and research, center for biologics evaluation and research. Q1B photostability testing of new drug substances and products. U.S. Food and Drug Administration. 1996."},{"key":"1448_CR27","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1039\/D3GC00800B","volume":"25","author":"PM Nowak","year":"2023","unstructured":"Nowak PM. What does it mean that \u201csomething is green\u201d? the fundamentals of a Unified greenness theory. Green Chem. 2023;25:4625\u201340.","journal-title":"Green Chem"},{"key":"1448_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.envpol.2011.10.025","volume":"162","author":"M Tobiszewski","year":"2012","unstructured":"Tobiszewski M, Namie\u015bnik J. PAH diagnostic ratios for the identification of pollution emission sources. Environ Pollut. 2012;162:110\u20139.","journal-title":"Environ Pollut"},{"key":"1448_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.greeac.2024.100126","volume":"10","author":"FR Mansour","year":"2024","unstructured":"Mansour FR, Omer KM, P\u0142otka-Wasylka J. A total scoring system and software for complex modified GAPI (ComplexMoGAPI) application in the assessment of method greenness. Green Anal Chem. 2024;10: 100126.","journal-title":"Green Anal Chem"},{"key":"1448_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2022.116553","volume":"149","author":"W Wojnowski","year":"2022","unstructured":"Wojnowski W, Tobiszewski M, Pena-Pereira F, Psillakis E. AGREEprep\u2014analytical greenness metric for sample preparation. TrAC Trends Anal Chem. 2022;149: 116553.","journal-title":"TrAC Trends Anal Chem"},{"key":"1448_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1039\/C6GC02157C","volume":"19","author":"RA Sheldon","year":"2017","unstructured":"Sheldon RA. The E factor 25 years on: the rise of green chemistry and sustainability. Green Chem. 2017;19:18\u201343.","journal-title":"Green Chem"},{"key":"1448_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.greeac.2023.100056","volume":"5","author":"PM Nowak","year":"2023","unstructured":"Nowak PM, Wietecha-Pos\u0142uszny R, P\u0142otka-Wasylka J, Tobiszewski M. How to evaluate methods used in chemical laboratories in terms of the total chemical risk?\u2014A ChlorTox Scale. Green Anal Chem. 2023;5: 100056.","journal-title":"Green Anal Chem"},{"key":"1448_CR33","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.trac.2008.05.003","volume":"27","author":"S Armenta","year":"2008","unstructured":"Armenta S, Garrigues S, De La Guardia M. Green analytical chemistry. TrAC Trends Anal Chem. 2008;27:497\u2013511.","journal-title":"TrAC Trends Anal Chem"},{"key":"1448_CR34","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.3390\/molecules29133205","volume":"29","author":"S El Deeb","year":"2024","unstructured":"El Deeb S. Enhancing sustainable analytical chemistry in liquid chromatography: guideline for transferring classical high-performance liquid chromatography and ultra-high-pressure liquid chromatography methods into greener, bluer, and whiter methods. Molecules. 2024;29:3205.","journal-title":"Molecules"},{"key":"1448_CR35","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1039\/C6GC03424A","volume":"19","author":"M Tobiszewski","year":"2017","unstructured":"Tobiszewski M, Namie\u015bnik J, Pena-Pereira F. Environmental risk-based ranking of solvents using the combination of a multimedia model and multi-criteria decision analysis. Green Chem. 2017;19:1034\u201342.","journal-title":"Green Chem"},{"key":"1448_CR36","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/etc.5620160237","volume":"16","author":"MB Swanson","year":"1997","unstructured":"Swanson MB, Davis GA, Kincaid LE, Schultz TW, Bartmess JE, Jones SL, et al. A screening method for ranking and scoring chemicals by potential human health and environmental impacts. Environ Toxicol Chem. 1997;16:372\u201383.","journal-title":"Environ Toxicol Chem"},{"key":"1448_CR37","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ecoenv.2015.05.043","volume":"120","author":"M Tobiszewski","year":"2015","unstructured":"Tobiszewski M, Namie\u015bnik J. Scoring of solvents used in analytical laboratories by their toxicological and exposure hazards. Ecotoxicol Environ Saf. 2015;120:169\u201373.","journal-title":"Ecotoxicol Environ Saf"},{"key":"1448_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.greeac.2023.100065","volume":"6","author":"PM Nowak","year":"2023","unstructured":"Nowak PM, Bis A, Zima A. ChlorTox Base\u2014a useful source of information on popular reagents in terms of chemical hazards and greenness assessment. Green Anal Chem. 2023;6: 100065.","journal-title":"Green Anal Chem"},{"key":"1448_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.teac.2022.e00194","volume":"37","author":"AR Hussein","year":"2023","unstructured":"Hussein AR, Gburi MS, Muslim NM, Azooz EA. A greenness evaluation and environmental aspects of solidified floating organic drop microextraction for metals: a review. Trends Environ Anal Chem. 2023;37: e00194.","journal-title":"Trends Environ Anal Chem"},{"key":"1448_CR40","doi-asserted-by":"publisher","first-page":"101013","DOI":"10.1016\/j.jpha.2024.101013","volume":"14","author":"L Yin","year":"2024","unstructured":"Yin L, Yu L, Guo Y, Wang C, Ge Y, Zheng X, et al. Green analytical chemistry metrics for evaluating the greenness of analytical procedures. J Pharm Anal. 2024;14:101013.","journal-title":"J Pharm Anal."},{"key":"1448_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","volume":"37","author":"A Ga\u0142uszka","year":"2012","unstructured":"Ga\u0142uszka A, Migaszewski ZM, Konieczka P, Namie\u015bnik J. Analytical Eco-Scale for assessing the greenness of analytical procedures. TrAC Trends Anal Chem. 2012;37:61\u201372.","journal-title":"TrAC Trends Anal Chem"},{"key":"1448_CR42","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1351\/pac-con-13-02-05","volume":"85","author":"C Turner","year":"2013","unstructured":"Turner C. Sustainable analytical chemistry—more than just being green. Pure Appl Chem. 2013;85:2217\u201329.","journal-title":"Pure Appl Chem"},{"key":"1448_CR43","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.1039\/C5AY01202C","volume":"7","author":"D Gallart-Mateu","year":"2015","unstructured":"Gallart-Mateu D, Cervera ML, Armenta S, De La Guardia M. The importance of incorporating a waste detoxification step in analytical methodologies. Anal Methods. 2015;7:5702\u20136.","journal-title":"Anal Methods"},{"key":"1448_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.greeac.2022.100023","volume":"3","author":"JM Kokosa","year":"2022","unstructured":"Kokosa JM, Przyjazny A. Green microextraction methodologies for sample preparations. Green Anal Chem. 2022;3: 100023.","journal-title":"Green Anal Chem"},{"key":"1448_CR45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1860-5397-2-3","volume":"2","author":"K Van Aken","year":"2006","unstructured":"Van Aken K, Strekowski L, Patiny L. EcoScale, a semi-quantitative tool to select an organic preparation based on economical and ecological parameters. Beilstein J Org Chem. 2006;2:3.","journal-title":"Beilstein J Org Chem"},{"key":"1448_CR46","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.trac.2010.03.009","volume":"29","author":"S Garrigues","year":"2010","unstructured":"Garrigues S, Armenta S, Guardia MDL. Green strategies for decontamination of analytical wastes. TrAC Trends Anal Chem. 2010;29:592\u2013601.","journal-title":"TrAC Trends Anal Chem"},{"key":"1448_CR47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00216-004-2906-5","volume":"381","author":"L Ramos","year":"2005","unstructured":"Ramos L, Ramos JJ, Brinkman UAT. Miniaturization in sample treatment for environmental analysis. Anal Bioanal Chem. 2005;381:119\u201340.","journal-title":"Anal Bioanal Chem"},{"key":"1448_CR48","unstructured":"UNECE. Globally harmonized system of classification and labelling of chemicals (GHS)."},{"key":"1448_CR49","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/9783527629688.ch16","volume-title":"Green chemistry in the pharmaceutical industry","author":"PJ Dunn","year":"2010","unstructured":"Dunn PJ, Wells AS, Williams MT. Future trends for green chemistry in the pharmaceutical industry. In: Dunn PJ, Wells AS, Williams MT, editors. Green chemistry in the pharmaceutical industry. 1st ed. Hoboken: Wiley; 2010. p. 333\u201355.","edition":"1"},{"key":"1448_CR50","first-page":"389","volume":"14","author":"W Wardencki","year":"2005","unstructured":"Wardencki W, Cury\u0142o J, Namie\u015bnik J. Green chemistry\u2013current and future issues. PolJ Env Stud. 2005;14:389\u201395.","journal-title":"PolJ Env Stud"},{"key":"1448_CR51","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.1039\/D3GC02347H","volume":"25","author":"N Manousi","year":"2023","unstructured":"Manousi N, Wojnowski W, P\u0142otka-Wasylka J, Samanidou V. Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality. Green Chem. 2023;25:7598\u2013604.","journal-title":"Green Chem"},{"key":"1448_CR52","doi-asserted-by":"publisher","first-page":"109824","DOI":"10.1016\/j.microc.2023.109824","volume":"197","author":"M Henrique Petrarca","year":"2024","unstructured":"Henrique Petrarca M, Vicente E, Amelia Verdiani Tfouni S. Single-run gas chromatography-mass spectrometry method for the analysis of phthalates, polycyclic aromatic hydrocarbons, and pesticide residues in infant formula based on dispersive microextraction techniques. Microchem J. 2024;197:109824.","journal-title":"Microchem J"},{"key":"1448_CR53","doi-asserted-by":"publisher","first-page":"2300101","DOI":"10.1002\/sscp.202300101","volume":"7","author":"B Olayanju","year":"2024","unstructured":"Olayanju B, Kabir A, Manousi N, Furton KG. Application of sol-gel universal sorbent coated fabric phase sorptive extraction membranes in combination with high-performance liquid chromatography-ultraviolet detection to monitor endocrine-disrupting chemicals in milk and environmental water samples. Sep Sci PLUS. 2024;7:2300101.","journal-title":"Sep Sci PLUS"},{"key":"1448_CR54","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1021\/acs.analchem.3c04392","volume":"96","author":"AA Essawy","year":"2024","unstructured":"Essawy AA, Alsohaimi IH, Hassan HMA, El Agammy EF, Hussein MF, Hasanin THA, et al. Basic Fuchsin dye as the first fluorophore for optical sensing of morpholine in fruits crust and urine samples. Anal Chem. 2024;96:373\u201380.","journal-title":"Anal Chem"},{"key":"1448_CR55","doi-asserted-by":"publisher","first-page":"2300142","DOI":"10.1002\/masy.202300142","volume":"413","author":"R Godela","year":"2024","unstructured":"Godela R, Venugopal M, Yagnambhatla R, Gugulothu S, Mayasa V, Maddukuri S, et al. Estimation of lexisinatide in bulk and tablets by RP-UPLC method developed by quality by design concept. Macromol Symp. 2024;413:2300142.","journal-title":"Macromol Symp"},{"key":"1448_CR56","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jpba.2015.07.003","volume":"115","author":"C Bouss\u00e8s","year":"2015","unstructured":"Bouss\u00e8s C, Ferey L, Vedrines E, Gaudin K. Using an innovative combination of quality-by-design and green analytical chemistry approaches for the development of a stability indicating UHPLC method in pharmaceutical products. J Pharm Biomed Anal. 2015;115:114\u201322.","journal-title":"J Pharm Biomed Anal"},{"key":"1448_CR57","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s43094-024-00659-5","volume":"10","author":"MV Nuli","year":"2024","unstructured":"Nuli MV, Seemaladinne R, Tallam AK. Analytical quality by design (AQbD) based optimization of RP-UPLC method for determination of nivolumab and relatlimab in bulk and pharmaceutical dosage forms. Fut J Pharm Sci. 2024;10:86.","journal-title":"Fut J Pharm Sci"},{"key":"1448_CR58","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1039\/D3EM00339F","volume":"25","author":"SS Saleh","year":"2023","unstructured":"Saleh SS, Lotfy HM, Elbalkiny HT. An integrated framework to develop an efficient valid green (EVG) HPLC method for the assessment of antimicrobial pollutants with potential threats to human health in aquatic systems. Environ Sci Process Impacts. 2023;25:2125\u201338.","journal-title":"Environ Sci Process Impacts"},{"key":"1448_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpbao.2024.100036","volume":"4","author":"NA Abd El-Fatah","year":"2024","unstructured":"Abd El-Fatah NA, Elbalkiny HT, Hegazy MA, Fouad MM, El-Sayed GM. Green analytical chemistry and quality by design: a combined approach towards simultaneous determination of Letrozole with its co-administered Zoledronic acid for cancer patients. J Pharm Biomed Anal Open. 2024;4: 100036.","journal-title":"J Pharm Biomed Anal Open"},{"key":"1448_CR60","doi-asserted-by":"publisher","first-page":"100193","DOI":"10.1016\/j.greeac.2024.100193","volume":"12","author":"V Manukonda","year":"2025","unstructured":"Manukonda V, Dandamudi SP, Kusuma PK, Thumma G, Gangarapu K. Development and validation of a UPLC-MS\/MS method for the simultaneous estimation of ertugliflozin and sitagliptin in bulk and tablet dosage forms: assessment of greenness and blueness. Green Analyt Chem. 2025;12:100193.","journal-title":"Green Analyt Chem"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01448-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-025-01448-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01448-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T05:43:20Z","timestamp":1742017400000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-025-01448-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1448"],"URL":"https:\/\/doi.org\/10.1186\/s13065-025-01448-8","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,15]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}